You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IV Non-small Cell Lunch Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Non Small Cell Lung Cancer Metastatic Trial (MRI)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • MRI
  • (no location specified)
May 16, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CS1001 monoclonal antibody
    • CS1001 placebo
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Nov 8, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • (no location specified)
    Jan 9, 2023

    Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • +3 more
    • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
    • quality-of-life assessment
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)

    Not yet recruiting
    • Stage IV Non-small Cell Lung Cancer
    • SBRT+Osimertinib
    • Osimertinib 80 MG
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated to Tongji Medical College of Huazhong
    Oct 13, 2022

    NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital & Institute
    Jul 21, 2022

    Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • IOV-4001
    • Louisville, Kentucky
    • +2 more
    Nov 21, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New Haven, Connecticut
    • +4 more
    Jan 27, 2023

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +3 more
    • Biopsy
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 9, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

    Completed
    • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
    • Stage IV Non-Small Cell Lung Cancer AJCC v7
    • Laboratory Biomarker Analysis
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 14, 2022

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Aldesleukin
    • Pembrolizumab
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Aug 8, 2022

    Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

    Active, not recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 10, 2022

    NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • primary tumour radiotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Stage IV
    • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
    • +2 more
    • Aarau, Switzerland
    • +7 more
    Oct 27, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +3 more
    • Poziotinib Hydrochloride
    • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
    • (no location specified)
    Jul 18, 2022

    Blood Samples in Patients With Non-small Cell Lung Cancer

    Recruiting
    • Stage III Non-Small Cell Lung Cancer AJCC v7
    • +3 more
    • Biospecimen Collection
    • Laboratory Biomarker Analysis
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 18, 2022

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

      Not yet recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Tumor treating fields（EFE-P100）
      • Docetaxel injection
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Dec 21, 2022